ICD-10-CM Billable Code

C49.1

Malignant neoplasm of connective and soft tissue of upper limb, including shoulder

Clinical Classification Guidelines

Medical Intelligence & Overview

Malignant neoplasm of connective and soft tissue of the upper limb, including the shoulder, is a type of cancer that originates in the soft tissues surrounding bones, muscles, fat, blood vessels, and nerves in the upper arm and shoulder region. This condition is classified under ICD-10 code C49.1. It is a serious form of cancer that requires medical diagnosis and treatment planning to manage its progression. Recognizing its signs and understanding the causes can aid in early detection and intervention.

Causes & Symptoms

Clinical Causes: Genetic mutations leading to abnormal cell growth Exposure to certain chemicals or radiation History of radiation therapy to the area Pre-existing benign soft tissue tumors that transform malignantly Rare hereditary syndromes associated with soft tissue cancers

Key Symptoms: Persistent swelling or a lump in the upper arm or shoulder Pain or tenderness at the tumor site Limited movement or stiffness in the shoulder or arm Numbness or tingling if the tumor compresses nearby nerves Unexplained weight loss or fatigue in advanced cases

Diagnostic & Treatment

Diagnosis Path: Diagnosing this type of cancer involves multiple steps. Initially, a physical examination assesses the lump’s size, tenderness, and mobility. Imaging tests like MRI, CT scans, or ultrasounds help visualize the tumor’s extent and relationship with surrounding tissues. A biopsy, where a tissue sample is taken for microscopic analysis, confirms the diagnosis and determines the cancer’s type and grade. Additional tests may include staging procedures such as chest X-rays or PET scans to check for spread beyond the primary site.

Treatment Protocols: Treatment strategies for malignant soft tissue tumors typically involve a combination of approaches tailored to the tumor’s size, location, type, and spread. Common options include: - **Surgical removal** of the tumor with clear margins to reduce recurrence risk - **Radiation therapy** to target residual cancer cells or shrink tumors prior to surgery - **Chemotherapy** to manage advanced disease or metastasis - **Targeted therapy** and immunotherapy may be considered depending on specific tumor markers A multidisciplinary team approach ensures comprehensive care, addressing both the tumor and preservation of limb function. Rehabilitation and follow-up care are essential components of ongoing management.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C49.1 a billable ICD-10 code?
Yes, C49.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C49.1?
Clinical documentation must specify the nature of Malignant neoplasm of connective and soft tissue of upper limb, including shoulder and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

shoulder neoplasm tissue connective malignant